Rosenthal, Philip, Schwarz, Kathleen B., Brainard, Diana M., Hsueh, Chia-Hsiang, Shao, Jiang, Parhy, Bandita, Davison, Suzanne, Feiterna-Sperling, Cornelia, Gillis, Lynette A., Indolfi, Giuseppe, Sokal, Etienne M., Murray, Karen F., Gonzalez-Peralta, Regino P., Wirth, Stefan, Lin, Chuan-Hao, Kelly, Deidre A., Nightingale, Scott, Balistreri, William F., Bansal, Sanjay, Jonas, Maureen M., Massetto, Benedetta. John Wiley & Sons; 2020. Sofosbuvir and ribavirin therapy for children aged 3 to <12 years with hepatitis C virus genotype 2 or 3 infection.